Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleRosiglitazone was noninferior to metformin plus sulfonylurea for CV events but increased risk for HF and fractures in type 2 diabetes.AuthorsLipscombe LL; Home PDPublicationACP Journal Club, 2009, Vol 151, Issue 4, p5ISSN1056-8751Publication typeJournal Article